Who is sponsoring NCT05242731?

NCT05242731 is sponsored by Isala.

What drugs are being tested in NCT05242731?

Interventions in NCT05242731: MSmonitor, a self-management/education program with e-health interventions, Video calling program "Better-close", Researchmanager program.

What condition does NCT05242731 study?

NCT05242731 studies Multiple Sclerosis.

Is NCT05242731 still recruiting?

NCT05242731 is currently status unknown. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT05242731: MonSter

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telemonitoring and Connected Care Applied to Multiple Sclerose

Status unknown NA Last updated 10 October 2023

What this trial tests

NA trial testing MSmonitor, a self-management/education program with e-health interventions in Multiple Sclerosis in 208 participants. Status unknown.

Timeline

29 April 2021

Primary endpoint
29 April 2024

31 December 2025

Quick facts

Lead sponsor	Isala
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	208
Start date	29 April 2021
Primary completion	29 April 2024
Estimated completion	31 December 2025
Sites	4 locations across Netherlands

Drugs / interventions tested

MSmonitor, a self-management/education program with e-health interventions
Video calling program "Better-close"
Researchmanager program

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Isala — full company profile →

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators designed a new care concept based on a multi-modal version of the MSmonitor program, the 'MSmonitor-Plus and Video Calling Care' (MPVC). MPVC combines the self-management and education program MSmonitor with video consultations by using specific questionnaires designed for high-frequency/intensive self-assessments of MS patients. 'The overall objective of this study is to assess the feasibility and (cost)-effectiveness of MPVC compared to Care as Usual (CAU). An RCT with two parallel groups will be conducted to compare the MPVC with a CAU in MS patients and their caregivers. In this study, 208 MS patients will be included with follow-up measurements for two years (at baseline and every three months). After randomization, 104 patients will be assigned to MPVC and 104 patients to CAU. The study will consist of three parts: 1) a clinical effectiveness study, 2) a cost-effectiveness study, and 3) process evaluation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial.
Hoving M, Jongen PJ, Evers SMAA, Edens MA, et al · · 2022 · PMID 36371162 · DOI 10.1186/s12883-022-02948-z

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Isala trials

Trials by the same sponsor.

NCT06342843 — Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH) · NA · recruiting
NCT05682027 — Ultrasound as Diagnostic Tool in Diaphragm Dysfunction · completed
NCT05860686 — Does Post-operative Rinsing With a Monoject Syringe Result in as Much Post-operative Pain After Surgical Removal of Lowe · NA · unknown
NCT05180955 — The Role of Clamping Before Removal of a Pneumothorax Drain Connected to a Digital Drainage System. · NA · completed
NCT05420974 — NIR Arthroscopic Fluorescence Angiography of Menisci · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05242731 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Isala
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05242731.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing